Arkolith/Funds/GENERAL ATLANTIC, L.P.

GENERAL ATLANTIC, L.P.

CIK: 1017645Q1 2026
Active Filer
Portfolio Value
$2.1B
Positions
13
New Buys
0
1 sold
Changes
1 ↑ / 4 ↓

Top HoldingsQ1 2026

13 total positions
#SecurityValueShares% PortChangeΔ Shares
1
DLOCAL
CL A
$605.1M46.66M28.2%
HELD
0
2CHIME
CL A
$398.2M21.26M18.5%
HELD
0
3
XP, INC
CL A
$391.6M20.57M18.2%
REDUCED
-2,133,000
4ALKAMI
COM
$240.3M15.34M11.2%
ADDED
+3.35M
5
PHARVARIS
COM
$226.9M8.03M10.6%
HELD
0
6EUROPEAN WAX CENTER
CL A
$75.8M13.11M3.5%
HELD
0
7REVOLUTION MEDICINES
COM
$68.8M707.8K3.2%
REDUCED
-2,105,137
8NURIX THERAPEUTICS
COM
$63.6M4.10M3.0%
REDUCED
-795,294
9CENTESSA PHARMACEUTICALS
ADS
$53.8M1.35M2.5%
REDUCED
-4,762,885
10
RISKIFIED
CL A
$20.9M5.32M1.0%
HELD
0
11GROVE COLLABORATIVE
CL A
$3.2M2.47M0.1%
HELD
0
12
WEBULL
ORD SHS
$244K50.8K0.0%
HELD
0
13ALIGNMENT HEALTHCARE
COM
$000.0%
EXITED
-13,167,733

Filing History

Q1 202612 pos
$2.1B
Q4 202513 pos
$2.9B

Data Source

Holdings data sourced from SEC EDGAR 13F-HR filings. Updated quarterly, approximately 45 days after quarter end. All data is public domain.

Last filed: May 15, 2026